Accolades
Sidley Recognized by China Business Law Journal for 13 “Deals of the Year” 2024
April 2, 2025
China Business Law Journal (CBLJ) has recognized Sidley for 13 “Deals of the Year” for 2024. Each year, CBLJ reviews the standout deals of the prior year, considering the “overall significance, complexity, innovative nature and deal size” of matters.
CBLJ has identified the following Sidley matters as “Deals of the Year”:
- Chinese EV companies defense against EU subsidies probe
- D3 Bio's US$40 million series A+ financing
- Evergrande's debt restructuring
- Hengrui's out-licenses GLP-1 to Hercules
- Kaisa's offshore debt restructuring
- Shang Gong’s stalking horse bid for ICON
- Shanghai Pharma's collaboration with Sanofi Aventis
- Shimao Group's debt restructuring
- Sunac’s US$10.2 billion offshore restructuring
- Tsinghua Unigroup's ups stake in H3C
- XtalPi (QuantumPharm)’s Hong Kong IPO
- Zeekr’s US$441 million NYSE IPO
- Zhongliang Holdings' debt restructuring
Capabilities
Suggested News & Insights
Sidley Ranked in Chambers Greater China Region 2026January 15, 2026Sidley Advises Achieve on Its Inaugural US$217 Million Debt Settlement Fee SecuritizationDecember 18, 2025Sidley Recognized for Helping Mainland Chinese Companies to “Go Global”December 18, 2025Sidley Advises Pan Brothers on Its US$533 Million Debt RestructuringDecember 17, 2025Sidley Secures Plan Confirmation in Prospect Medical Holdings' US$2.3 Billion Chapter 11 CaseDecember 17, 2025Sidley Elects 2026 Partnership and Counsel Classes Across Europe and the U.S.December 11, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory